per year, accounting for 45% primary cardiac tumors in adults and 15% in children. [3] Recurrence is reported in sporadic (4%-7%) and familial cases (10%-21%) with the interval between the formation of the new tumor of more than 4 years. [4] Although well documented in the adult population, information about cerebral embolism in the pediatric population is still limited. [5] The following case illustrates a combination of the two rare diseases clinically presenting with a cerebral stroke and an extremely rapid recurrence of the left atrial myxoma in a teenager.
Introduction
The Carney complex (CNC) [1] is a rare dominantly inherited syndrome characterized by skin pigment abnormalities, endocrine over activity and cardiac myxomas. About 600 patients worldwide have been reported by the National Institute of Health (NIH) -Mayo Clinic (USA) and the Cochin centre (France) by January 2008. [2] Cardiac myxomas are rare benign tumors with an estimated incidence of 0.5-1 per million population Health, University of Washington, and Seattle) [6] where it was confi rmed protein kinase A regulatory subunit 1A mutation (PRKAR1A), c418_419delCA het in exon 4 in our patient. The genetic investigation of the family was negative, the girl obviously being a new mutation.
Her routine follow up at 1, 3, 6, 12, and 24 months showed no new cardiac masses.
Results
Intracardiac tumors in the pediatric age group are rare with an incidence of 0.17% in children. Myxomas account for 6% of all pediatric cardiac tumors after rhabdomyomas (63%) and fi bromas (6%). Recurrence of the tumor has been reported with the majority of patients being reoperated more than four years after the initial surgery. [7] Carney complex is a genetic disease inherited in an autosomal dominant manner, one of the additional criteria being a myxoma (cutaneous, cardiac, breast or bone). [8] Our patient with atrial myxoma had a de novo Carney complex diagnosed after an extremely short recurrence period of the cardiac tumor.
Comment
The Carney complex associated with myxoma of various locations is being extensively studied in connection with associated genetic abnormalities. The most interesting controversy is a rather frequent recurrence of myxoma after complete resection, the fact not observed in most benign neoplasms. In spite of low incidence of the Carney complex, its diagnosis is often established after several years of neurological symptoms and abnormal and clearly visible skin pigmentation. This report supports the possibility of an early recurrence of cardiac myxoma, more likely to be attributed to its underlying genetic nature, rather than incomplete surgical resection.
